Sign in →

Test Code LABCORDRG Toxicology Drug Screen, Umbilical Cord Segment

Clinical Information

The analysis of drugs in umbilical cord tissue (UCT) is intended to assess drug exposure during pregnancy. The presences or absence, deposition, concentration, and time frame of detectability for drugs in UCT does not necessarily parallel that of othe specimens such as meconium, newborn urine, and maternal urine. therefore, drugs detected or expected in maternal specimens and other newborn specimens may not match identified drugs in UCT. Drugs administered during labor may be present in UCT and negative results do not exclude the possibility of drug exposure during pregnancy.

Synonym

  • CORDRG
  • UCT
  • Umbilical Cord

Profile Information

Reporting Name Available Separately Always Reported
Amphetamine, Cord No Yes
Methamphetamine, Cord No Yes
2-Hydroxyethylflurazepam, Cord No Yes
7-Aminoclonazepam, Cord No Yes
7-Aminoflunitrazepam, Cord No Yes
Alpha-OH-Alprazolam, Cord No Yes
Alpha-OH-Midazolam, Cord No Yes
Alprazolam, Cord No Yes
Clonazepam, Cord No Yes
Diazepam, Cord No Yes
Flurazepam, Cord No Yes
Lorazepam, Cord No Yes
Midazolam, Cord No Yes
Nordiazepam, Cord No Yes
Oxazepam, Cord No Yes
Temazepam, Cord No Yes
Buprenorphine, Cord No Yes
Norbuprenorphine, Cord No Yes
Cocaine, Cord No Yes
Benzoylecgonine, Cord No Yes
Fentanyl, Cord No Yes
Norfentanyl, Cord No Yes
Gabapentin, Cord No Yes
6-Monoacetylmorphine, Cord No Yes
Ketamine, Cord No Yes
Norketamine, Cord No Yes
Methadone, Cord No Yes
Methadone Metabolite (EDDP), Cord No Yes
Methylphenidate, Cord No Yes
Ritalinic Acid, Cord No Yes
Codeine, Cord No Yes
Morphine, Cord No Yes
Hydrocodone, Cord No Yes
Hydromorphone, Cord No Yes
Naloxone, Cord No Yes
Meperidine, Cord No Yes
Normeperidine, Cord No Yes
Nalbuphine, Cord No Yes
Noroxycodone, Cord No Yes
Oxycodone, Cord No Yes
Oxymorphone, Cord No Yes
Phencyclidine (PCP), Cord No Yes
Pregabalin, Cord No Yes
Tramadol, Cord No Yes
Quetiapine, Cord No Yes
Mitragynine, Cord No Yes
Xylazine, Cord No Yes
Zolpidem, Cord No Yes
Zopiclone, Cord No Yes

Specimen Required

Preferred Container/Tube: Cup
Acceptable Container/Tube: Sterile Cup
Specimen Volume: 6 inches of umbilical cord tissue
Specimen Minimum Volume: 3 inches of umbilical cord tissue

Specimen Collection Information

Take 6" cord segment and gently run cord segment between thumb and forefinger 3-4 times to remove residual blood.  Rinse with saline and pat dry.

Specimen Stability Information

Refrigerated: 14 days
Frozen: 5 months stored less than -20C

Rejection Due To

  • Quantity not sufficient
  • Formalin fixed

Reference Values

None Detected

 

Cutoff concentrations:

Amphetamine  0.2 ng/g
Methamphetamine 0.5 ng/g
2-Hydroxyethylflurazepam  1.0 ng/g
7-Aminoclonazepam  0.2 ng/g
7-Aminoflunitrazepam  0.2 ng/g
alpha-Hydroxyalprazolam  1.0 ng/g
alpha-Hydroxymidazolam  0.2 ng/g
Alprazolam 0.1 ng/g
Clonazepam  10 ng/g
Diazepam  0.2 ng/g
Flurazepam  0.1 ng/g
Lorazepam  50 ng/g
Midazolam  0.2 ng/g
Nordiazepam  0.5 ng/g
Oxazepam  2.5 ng/g
Temazepam  0.5 ng/g
Buprenorphine  0.5 ng/g
Norbuprenorphine  0.5 ng/g
Cocaine  0.2 ng/g
Benzoylecgonine 0.5 ng/g
Fentanyl 0.5 ng/g
Norfentanyl 0.5 ng/g
Gabapentin  10 ng/g
6-Monoacetylmorphine  0.1 ng/g
Ketamine  0.1 ng/g
Norketamine 0.2 ng/g
Methadone  0.1 ng/g
EDDP Methadone  0.2 ng/g
Methylphenidate  0.1 ng/g
Ritalinic Acid  50 ng/g
Codeine  0.5 ng/g
Morphine  0.5 ng/g
Hydrocodone  0.2 ng/g
Hydromorphone  0.1 ng/g
Naloxone  0.2 ng/g
Meperidine  0.1 ng/g
Normeperidine  0.1 ng/g
Nalbuphine  0.5 ng/g
Noroxycodone  0.2 ng/g
Oxycodone  0.2 ng/g
Oxymorphone  0.5 ng/g
Phencyclidine  0.2 ng/g
Pregabalin  50 ng/g
Tramadol  0.1 ng/g
Quetiapine  0.2 ng/g
Mitragynine  0.5 ng/g
Xylazine  0.2 ng/g
Zolpidem  0.1 ng/g
Zopiclone  0.2 ng/g

Interpretation

Drugs and/or metabolites reported "Positive" were detected above the cutoff and indicate exposure to that drug/parent drug during gestation up to birth. 

 

Drugs and/or metabolites reported "None Detected" were not detected above the cutoff. These results do NOT preclude the possibility that the mother used this drug during pregnancy. 

Cautions

Detection of drugs in umbilical cord tissue is dependent on the concentration of the drug in the specimen. False negative results may occur if the drug concentration in umbilical cord tissue is below the cutoff. Negative results do not indicate that the mother did not use a drug during pregnancy.  Interfering substances in umbilical cord tissue may impede the detection of certain drugs. 

Drugs given to the mother during delivery may be detected in umbilical cord tissue.

 

Positive results do not indicate impairment.

 

Drugs detected in umbilical cord tissue may not parallel that of other specimens such as meconium, newborn urine, and maternal urine due to differences in drug deposition, concentration, and time of exposure.

Method Description

Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

Test Classification

This Liquid Chromatography/Mass Spectrometry (LC/MS/MS) test was developed and its performance characteristics determined by the Toxicology Laboratory at The Ohio State University Wexner Medical Center. It has not been cleared or approved by the FDA. The laboratory is regulated under CLIA as qualified to perform high complexity testing. This test is used for clinical purposes and should not be regarded as investigational or for research.

Performing Lab

Clinical Lab UH

Day(s) Performed

Monday through Friday

Report Available

1 to 3 days

Reporting Name

Toxicology, Umbilical Cord Segment

CPT Code Information

80324
80347
80348
80353
80354
80355
80356
80357
80358
80360
80364
80365
83992
80366
80373
80342
80323
80375
80368
G0480 x19 (if appropriate)

LOINC Code Information

29530-3
40381-6
59688-2
97212-5
61034-5
61037-8
97278-6
61038-6
61039-4
61074-1
61080-8
61044-4
59712-0
61051-9
61055-0
61061-8
82373-2
82375-7
40625-6
40609-0
61042-8
61051-9
103668-0
32099-4
61043-6
105974-0